Biosion

Nanjing, China · Founded 2017 · Privately Held (backing)

Developer of biomedical drugs intended for the treatment of immune and oncologic diseases. Biosion is based in Nanjing, China and was founded in 2017. Its last reported valuation was $182 million in Dec 2020. It has raised $133 million.

Last reported valuation
$182.3M
Oct 2026
Priced at
—
Total raised
$132.7M
Last round
—

Who backs Biosion?

17 investors
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Biosion investors

17 investors are on record for Biosion, including Addor Capital, Suzhou Guofa Venture Capital, Lapam Capital and GF Xinde Investment Management.

Free account
More of Biosion with a free account
  • ·The complete investor list: 17 names
  • ·Watch Biosion: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 17 firms already write checks for companies like Biosion. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View